| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/27/2000 | CN1267727A New human phosphorylated zymoprotein of pyruvate dehydrogenase and its code sequence |
| 09/27/2000 | CN1267726A New human zinc-finger protein and its code sequence |
| 09/27/2000 | CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 09/26/2000 | US6124448 Nucleic acid primers and probes for the mammalian OB gene |
| 09/26/2000 | US6124447 Nucleic acid sequence coding protein which serves as a substrate for cathepsins and has a enzymatic activity which releases phosphoric acid from preferential proteins; for use as an insecticide |
| 09/26/2000 | US6124446 Polynucleotide sequence coding a vacuolar separation polypeptide; for the diagnosis, treatment, and prevention of cancer, inflammatory, lysosomal storage and membrane transport defects; anticarciongenic agents |
| 09/26/2000 | US6124439 OB polypeptide antibodies and method of making |
| 09/26/2000 | US6124438 Receptor protein which preferentially binds to neuronal tissues; for detection of injury to animal neuronal tissues |
| 09/26/2000 | US6124437 Preparing antibodies solution; incubation of solution with colloidal silica, filtering solution through membrane, recover an antibody solution free of insoluble material |
| 09/26/2000 | US6124434 Human protein capable of adjustments in yeast; for the diagnosis, treatment and detection of cancer and cell proliferation defects; antitumor agents; anticarcinogenic agents |
| 09/26/2000 | US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein |
| 09/26/2000 | US6124267 O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1 |
| 09/26/2000 | US6124262 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 09/26/2000 | US6124132 Immunoglobulin for the passive prevention of viral infection |
| 09/26/2000 | US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen |
| 09/26/2000 | US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells |
| 09/26/2000 | US6124125 Nucleic acid sequence which codes mammalian emzymatic protein; for treatment of hypercholesterolemia, myocardium necrosis, hyperlipidemia, dietetics, stroke, nutrient defects and diabetes |
| 09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
| 09/26/2000 | US6124118 Receptor recognition factors, protein sequences and methods of use thereof |
| 09/26/2000 | US6124107 Screening for fibrinogen cleavage peptides in a sample of a body fluid; mixing sample with anticoagulent, centrifuging, recovering supernatant, incubate with antibodies, screening for antibody/peptide complex |
| 09/26/2000 | US6124105 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 09/26/2000 | US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control |
| 09/26/2000 | US6124095 Human nucleotide pyrophosphohydrolase-2 |
| 09/26/2000 | US6123941 Method for restoration of normal phenotype in cancer cells |
| 09/26/2000 | US6123939 Anti-neoplastic drugs in cancer therapy |
| 09/26/2000 | US6123938 Human urinary hyaluronidase |
| 09/26/2000 | CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 09/26/2000 | CA2024562C Cho cells transformed with a recombinant plasmid expressing human thyroid peroxidase and preparation thereof |
| 09/21/2000 | WO2000055633A2 Methods of screening for colorectal cancer modulators |
| 09/21/2000 | WO2000055377A1 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE |
| 09/21/2000 | WO2000055371A1 27 human secreted proteins |
| 09/21/2000 | WO2000055352A2 50 human secreted proteins |
| 09/21/2000 | WO2000055351A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055350A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |
| 09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/21/2000 | WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055308A1 A NOVEL COMPLEX OF HUMAN KALLIKREIN 2 (hK2) AND PROTEASE INHIBITOR-6 (PI-6) IN PROSTATE TUMOR TISSUE AND METHODS OF USING THE COMPLEX |
| 09/21/2000 | WO2000055305A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 09/21/2000 | WO2000055302A2 Genetically modified plants having modulated brassinosteroid signaling |
| 09/21/2000 | WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/21/2000 | WO2000055201A1 49 human secreted proteins |
| 09/21/2000 | WO2000055200A1 50 human secreted proteins |
| 09/21/2000 | WO2000055199A1 47 human secreted proteins |
| 09/21/2000 | WO2000055198A1 50 human secreted proteins |
| 09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
| 09/21/2000 | WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains |
| 09/21/2000 | WO2000055180A2 Human lung cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055177A2 49 human secreted proteins |
| 09/21/2000 | WO2000055176A2 49 human secreted proteins |
| 09/21/2000 | WO2000055175A1 50 human secreted proteins |
| 09/21/2000 | WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055171A1 50 human secreted proteins |
| 09/21/2000 | WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 09/21/2000 | WO2000054814A1 Screening methods for compounds useful in the regulation of cell proliferation |
| 09/21/2000 | WO2000054806A1 Insulin-like growth factor binding protein-4 protease |
| 09/21/2000 | WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 09/21/2000 | WO2000054804A1 Use of tgf-beta inhibitors for treating cerebral disorders |
| 09/21/2000 | WO2000054604A1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 09/21/2000 | WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy |
| 09/21/2000 | WO2000040201A3 Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin |
| 09/21/2000 | WO2000039154A3 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 09/21/2000 | WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use |
| 09/21/2000 | WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 09/21/2000 | WO2000026227A9 Ldl related protein and uses thereof |
| 09/21/2000 | WO2000023579A9 Functionally assembled antigen-specific intact recombinant antibody and a method for production thereof |
| 09/21/2000 | WO2000023477A9 Immunoglobulin variants |
| 09/21/2000 | WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 09/21/2000 | WO2000021550A8 Methods and compositions for treating neurodegenerative diseases |
| 09/21/2000 | WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 09/21/2000 | WO2000019205A9 Inhibition of pak activation of raf-1 |
| 09/21/2000 | WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/21/2000 | DE19910419A1 Zielzellspezifische, multivalente Proteine (MVP) Target cell-specific, multivalent proteins (MVP) |
| 09/21/2000 | CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 09/21/2000 | CA2368068A1 27 human secreted proteins |
| 09/21/2000 | CA2367906A1 Tcl-1b gene and protein and related methods and compositions |
| 09/21/2000 | CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells |
| 09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2365540A1 A novel complex of human kallikrein 2 (hk2) and protease inhibitor-6 (pi-6) in prostate tumor tissue and methods of using the complex |
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364650A1 50 human secreted proteins |
| 09/21/2000 | CA2364637A1 50 human secreted proteins |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2364630A1 50 human secreted proteins |
| 09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364568A1 Method for refolding molecules of polypeptides containing ig domains |
| 09/21/2000 | CA2364549A1 50 human secreted proteins |
| 09/21/2000 | CA2363022A1 49 human secreted proteins |
| 09/21/2000 | CA2363019A1 49 human secreted proteins |
| 09/21/2000 | CA2362532A1 Screening of antiviral compounds targeted to the hiv-1 gp41 core structure |
| 09/21/2000 | CA2361277A1 49 human secreted proteins |
| 09/20/2000 | EP1036798A1 Peptides having anti-cell adhesion activity |
| 09/20/2000 | EP1036188A1 ribG |
| 09/20/2000 | EP1036175A1 Human brain derived kcnq2 potassium channel |
| 09/20/2000 | EP1036168A1 Purification and microsequencing of hyaluronidase isozymes |
| 09/20/2000 | EP1036165A1 Human rnase h and compositions and uses thereof |